Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1988 1
1989 1
1993 1
2009 2
2022 4
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis.
Ytterberg SR, Bhatt DL, Mikuls TR, Koch GG, Fleischmann R, Rivas JL, Germino R, Menon S, Sun Y, Wang C, Shapiro AB, Kanik KS, Connell CA; ORAL Surveillance Investigators. Ytterberg SR, et al. N Engl J Med. 2022 Jan 27;386(4):316-326. doi: 10.1056/NEJMoa2109927. N Engl J Med. 2022. PMID: 35081280 Clinical Trial.
Olokizumab versus Placebo or Adalimumab in Rheumatoid Arthritis.
Smolen JS, Feist E, Fatenejad S, Grishin SA, Korneva EV, Nasonov EL, Samsonov MY, Fleischmann RM; CREDO2 Group. Smolen JS, et al. N Engl J Med. 2022 Aug 25;387(8):715-726. doi: 10.1056/NEJMoa2201302. N Engl J Med. 2022. PMID: 36001712 Clinical Trial.
Vascular complications based on mode of extracorporeal membrane oxygenation.
Blakeslee-Carter J, Shao C, LaGrone R, Gonzalez-Sigler I, Sutzko DC, Pearce B, Eudailey K, Spangler E, Beck AW, McFarland GE. Blakeslee-Carter J, et al. Among authors: lagrone r. J Vasc Surg. 2022 Jun;75(6):2037-2046.e2. doi: 10.1016/j.jvs.2022.01.078. Epub 2022 Jan 26. J Vasc Surg. 2022. PMID: 35090988 Free PMC article.
The Treatment for Adolescents With Depression Study (TADS): outcomes over 1 year of naturalistic follow-up.
Treatment for Adolescents With Depression Study (TADS) Team; March J, Silva S, Curry J, Wells K, Fairbank J, Burns B, Domino M, Vitiello B, Severe J, Riedal K, Goldman M, Feeny N, Findling R, Stull S, Baab S, Weller EB, Robbins M, Weller RA, Jessani N, Waslick B, Sweeney M, Dublin R, Walkup J, Ginsburg G, Kastelic E, Koo H, Kratochvil C, May D, LaGrone R, Vaughan B, Albano AM, Hirsch GS, Podniesinki E, Chu A, Reincecke M, Leventhal B, Rogers G, Jacobs R, Pathak S, Wells J, Lavanier SA, Danielyan A, Rohde P, Simons A, Grimm J, Frank S, Emslie G, Kennard B, Hughes C, Mayes TL, Rosenberg D, Benazon N, Butkus M, Bartoi M. Treatment for Adolescents With Depression Study (TADS) Team, et al. Among authors: lagrone r. Am J Psychiatry. 2009 Oct;166(10):1141-9. doi: 10.1176/appi.ajp.2009.08111620. Epub 2009 Sep 1. Am J Psychiatry. 2009. PMID: 19723787 Clinical Trial.
Assessment of safety and long-term outcomes of initial treatment with placebo in TADS.
Kennard BD, Silva SG, Mayes TL, Rohde P, Hughes JL, Vitiello B, Kratochvil CJ, Curry JF, Emslie GJ, Reinecke MA, March JS; TADS. Kennard BD, et al. Am J Psychiatry. 2009 Mar;166(3):337-44. doi: 10.1176/appi.ajp.2008.08040487. Epub 2009 Jan 15. Am J Psychiatry. 2009. PMID: 19147693 Free PMC article. Clinical Trial.